Ignite Creation Date:
2025-12-24 @ 10:12 PM
Ignite Modification Date:
2026-01-05 @ 12:44 AM
Study NCT ID:
NCT05514535
Status:
COMPLETED
Last Update Posted:
2025-11-25
First Post:
2022-08-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-29
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-04-09
Completion Date Type:
ACTUAL
First Submit Date:
2022-08-22
First Submit QC Date:
None
Study First Post Date:
2022-08-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-24
Last Update Post Date:
2025-11-25
Last Update Post Date Type:
ESTIMATED